|
Ranking of fifteen disease stages according to mean visual analogue scale values in 5 Western European countries and by professional category (standard deviation in parentheses). |
||||||||
| All |
England |
France |
Netherlands |
Spain |
Sweden |
Health care professionals |
Non-health care professionals |
|
| Disease stages |
(n = 230) |
(n = 49) |
(n = 46) |
(n = 50) |
(n = 46) |
(n = 39) |
(n = 111) |
(n = 119) |
|
|
||||||||
| Common cold |
0.03 (0.04) |
0.04 (0.06) |
0.03 (0.02) |
0.03 (0.04) |
0.04 (0.04) |
0.03 (0.03) |
0.03 (0.04) |
0.03 (0.04) |
| Vision disorder (mild/moderate) |
0.17 (0.17) |
0.17 (0.14) |
0.29 (0.29) |
0.13 (0.08) |
0.15 (0.11) |
0.14 (0.08) |
0.22 (0.22) |
0.13 (0.09) |
| Breast cancer (disease-free stage without sequelae) |
0.32 (0.18) |
0.37 (0.22) |
0.29 (0.19) |
0.27 (0.14) |
0.39 (0.15) |
0.26 (0.14) |
0.33 (0.17) |
0.30 (0.18) |
| Chronic low back pain |
0.33 (0.18) |
0.37 (0.20) |
0.34 (0.17) |
0.28 (0.15) |
0.32 (0.16) |
0.36 (0.20) |
0.30 (0.17) |
0.36 (0.18) |
| Uncomplicated diabetes |
0.34 (0.16) |
0.40 (0.17) |
0.30 (0.14) |
0.31 (0.15) |
0.31 (0.14) |
0.37 (0.16) |
0.36 (0.16) |
0.31 (0.15) |
| Mild dementia |
0.46 (0.21) |
0.50 (0.23) |
0.46 (0.23) |
0.46 (0.20) |
0.47 (0.19) |
0.41 (0.21) |
0.47 (0.20) |
0.45 (0.22) |
| Severe asthma |
0.46 (0.19) |
0.53 (0.20) |
0.43 (0.23) |
0.43 (0.16) |
0.43 (0.17) |
0.48 (0.15) |
0.49 (0.18) |
0.43 (0.19) |
| Colorectal cancer (diagnosis and primary therapy) |
0.51 (0.20) |
0.53 (0.22) |
0.48 (0.21) |
0.47 (0.14) |
0.64 (0.15) |
0.41 (0.18) |
0.49 (0.18) |
0.53 (0.21) |
| AIDS (minor symptoms and HAART) |
0.55 (0.22) |
0.56 (0.21) |
0.60 (0.22) |
0.43 (0.21) |
0.65 (0.21) |
0.52 (0.20) |
0.56 (0.22) |
0.54 (0.22) |
| Severe stable angina (NYHA3) |
0.59 (0.16) |
0.65 (0.15) |
0.58 (0.18) |
0.54 (0.13) |
0.59 (0.14) |
0.56 (0.15) |
0.59 (0.15) |
0.58 (0.17) |
| Acute myocardial infarction |
0.59 (0.20) |
0.64 (0.22) |
0.61 (0.22) |
0.49 (0.16) |
0.67 (0.16) |
0.52 (0.18) |
0.57 (0.20) |
0.60 (0.20) |
| Stroke (moderate permanent impairments) |
0.68 (0.16) |
0.69 (0.17) |
0.68 (0.17) |
0.64 (0.17) |
0.75 (0.13) |
0.64 (0.15) |
0.66 (0.17) |
0.70 (0.15) |
| Severe depression |
0.78 (0.17) |
0.74 (0.22) |
0.77 (0.21) |
0.82 (0.12) |
0.76 (0.13) |
0.83 (0.14) |
0.78 (0.18) |
0.78 (0.17) |
| Quadriplegia |
0.91 (0.10) |
0.89 (0.12) |
0.93 (0.07) |
0.89 (0.07) |
0.94 (0.06) |
0.88 (0.13) |
0.90 (0.10) |
0.91 (0.09) |
| Final year of unspecified fatal disease |
0.91 (0.10) |
0.92 (0.09) |
0.96 (0.05) |
0.87 (0.11) |
0.95 (0.06) |
0.87 (0.12) |
0.90 (0.11) |
0.93 (0.09) |
|
Acquired Immune Deficiency Syndrome (AIDS); Highly Active Anti-Retroviral Therapy (HAART); New-York Heart Association (NYHA) | ||||||||
Schwarzinger et al. Population Health Metrics 2003 1:9 doi:10.1186/1478-7954-1-9 |
||||||||